In vivo results showed the attenuation of primary tumor growth and metastatic potential of breast cancer cells after Cx43 over-expression, whereas Cx43 knock-down induced a more aggressive metastatic phenotype. This evidence concerns the gene GJA1 and breast carcinoma.